Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting

NCT02104154 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2015-02-20

No results posted yet for this study

Summary

To establish the performance characteristics of the Samsung LABGEO PT10 by comparing the test results of the PT10 Hepatic assay with results obtained from an FDA-cleared chemistry analyzer.

Conditions

  • Hepatic Disease

Interventions

DEVICE

Samsung LABGEO PT10 Hepatic Panel

Sponsors & Collaborators

  • Samsung Electronics

    lead INDUSTRY

Principal Investigators

  • Nam Shin · Nexus DX

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104154 on ClinicalTrials.gov